TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Drugs AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
341,924
|
283,846
|
234,093 |
Financial expenses |
14
|
71
|
109 |
Earnings before taxes |
15,098
|
-2,810
|
-3,342 |
EBITDA |
14,284
|
-3,711
|
-4,322 |
Total assets |
172,397
|
131,575
|
144,763 |
Current assets |
171,281
|
129,294
|
141,229 |
Current liabilities |
68,319
|
43,433
|
48,511 |
Equity capital |
99,176
|
83,587
|
90,005 |
- share capital |
20,261
|
18,918
|
19,504 |
Employees (average) |
25
|
26
![]() |
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.5%
|
63.5%
|
62.2% |
Turnover per employee |
13,677
|
10,917
|
9,004 |
Profit as a percentage of turnover |
4.4%
|
-1.0%
|
-1.4% |
Return on assets (ROA) |
8.8%
|
-2.1%
|
-2.2% |
Current ratio |
250.7%
|
297.7%
|
291.1% |
Return on equity (ROE) |
15.2%
|
-3.4%
|
-3.7% |
Change turnover |
37,937
|
56,788
|
-44,850 |
Change turnover % |
12%
|
25%
|
-16% |
Chg. No. of employees |
-1
|
0
|
-1 |
Chg. No. of employees % |
-4%
|
0%
|
-4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.